Target-directed cancer: protein-ligand interactions
Drug Target Review
NOVEMBER 1, 2023
We need to build the assays that we need for compound screening. For biochemical assays, biophysics, and the structural techniques, we will need to generate recombinant versions of the protein drug target. We are involved from a very early stage once a target is validated.
96 
Let's personalize your content